Kezar Life Sciences
KZR7.2900.00% ( 0.000 )
Kezar Life Sciences (KZR)
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 7.290
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 7.550
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Kezar Life Sciences Analyst Rating
View MoreForecast & Rating
Apr 26, 2026Price forecast
$6.00-17.70%
Forecast & RatingHold
3analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · May 12 at 01:01 AM
Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for Investors
- Tip Ranks · May 11 at 08:59 AM
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
- TradingView · May 11 at 08:33 AM
Kevin Tang named CEO of Kezar Life Sciences as multiple directors and officers resign
- TradingView · May 11 at 08:33 AM
Kezar Life Sciences Announced Transfer or Voluntary Withdrawal of Listing
- Market Beat · May 5 at 03:12 AM
Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by Analysts
- prnewswire · Apr 14 at 03:14 PM
16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?
